secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0001493152-24-047742
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharmaceuticals stockholders approve 2.26M share increase to equity plan
----------------------------------------------------------------------------

- Stockholders re-elected all seven director nominees: Glass, Eagle, Schreiber, Silverman, Uzonwanne, White, Friscia.
- Equity plan share reserve increased by 2,259,060 to 2,500,000 total, approved with 2.92M for and 116K against.
- Stephano Slack LLC ratified as independent auditor for FY 2024 with 3.74M votes for.
- Adjournment proposal approved with 3.42M votes for to permit further solicitation if needed.
- Voting results final; no other matters considered at the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224047742/0001493152-24-047742-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224047742/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047742

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer